Bio
Dr. Sebastian Schäfer is an Assistant Professor at Duke-NUS Medical School in Singapore and studied biological engineering in Nuremberg, Busan and Boston at Harvard-MIT. He received his doctoral degree in Genetics from the Max Delbrück Center, Berlin. His research focusses on the human translatome, the IL-6 family of cytokines and antibody therpautics. Sebastian published in Nature, Science, Nature Medicine, and Nature Genetics. As a Founder of Enleofen Bio, a Singapore-based biotech company, his team developed first-in-class antibodies currently in clinical trials.
Education
Doctor of Natural Science
Humboldt-Universitaet zu Berlin, Germany
Master of Engineering
Friedrich-Alexander University, Germany
Master of Science
Dongseo University, Korea, Republic of